References
- Müller-Lissner S. Adverse affects of laxatives: facts and fiction. Pharmacology, 1993, 47: 138–45.
- White C. S., Templeton P. A. Chemical pneumonitis. Radiol Clinics of North America, 1992, 30: 1231–1243.
- Jafri S., Parisha P. J. Agents used in diarrhea, constipation and inflammatory bowel disease, agents used for biliary and pancreatic disease. Stimulant (irritant) laxatives. In: Hardman J. G., Limbird L. E., Goodman-Goldman A. (eds.). The pharmacological basis of therapeutics. McGraw-Hill, New York, 2001, 1046.
- Reynolds J. Gastro-intestinal agents. In: Reynolds J. (ed.). The extra pharmacopoeia. Martindale, 29th edition, London, 1989, 1078.
- Valentzas C., Ikkos D. Phenolphthalein, cause of factitious enteritis. JAMA, 1971, 217: 966.
- Dunnick J., Hailey J. Phenolphthalein exposure causes multiple carcinogenic effects in experimental model systems. Cancer research, 1996, 56: 4922–6.
- Longnecker M, Sandler D, Haile R., Sandler R. Phenol-phthalein-containing laxative use in relation to adenomatous colorectal polyps en three studies. Environmental Health Perspectives, 1997, 105: 1210–12.
- Mengs U., Rudolf R. Light and electron-microscopic changes in the colon of the Guinea pig after treatment with anthranoid and non-anthranoid laxatives. Pharmacology, 1993, 47: 172–7.
- Saunders D., Sillery J., Rachmilewitz D., Rubin C., Tytgat G. Effect of bisacodyl on the structure and function of rodent and human intestine. Gastroenterology, 1977, 72: 849–56.
- Saunders D., Haggit R., Kimmey M., Silverstein F. Morphological consequences of bisacodyl on normal human rectal mucosa: effect of a prostaglandin E1 analogue on mucosal injury. Gastrointestinal endoscopy, 1990, 36: 101–4.
- Kapucu L., Meltzer C., Townsend D., Keenan R., Luketich J. Fluorine-18-fluorodeoxyglucose uptake in pneumonia. J Nucl Med, 1998, 39: 1267–9.
- Bakheet S., Saleem M., Powe J., Al Amro A., Larson S., Mahassin Z. F-18-fluorodeoxyglucose chest uptake in lung inflammation and infection. Clin. Nucl Med, 2000, 25: 273–8.
- Lee J., Aronchick J., Alavi A. Accuracy of F-18-fluorodeoxy-glucose positron emission tomography for the evaluation of malignancy in patients presenting with new lung abnormalities. Chest, 2001, 120: 1791–7.
- Bakheet S., Powe J. Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med, 1998, 28: 352–358.